Recent Progress in HIV-Associated Nephropathy

被引:42
|
作者
Wyatt, Christina M. [1 ]
Meliambro, Kristin [1 ]
Klotman, Paul E. [2 ]
机构
[1] Mt Sinai Sch Med, Dept Med, Div Nephrol, New York, NY 10029 USA
[2] Baylor Coll Med, Dept Med, Div Nephrol, Houston, TX 77030 USA
来源
关键词
HIV; kidney disease; pathogenesis; epidemiology; STAGE RENAL-DISEASE; ADHESION MOLECULE SIDEKICK-1; CHRONIC KIDNEY-DISEASE; ANTIRETROVIRAL THERAPY; PODOCYTE PROLIFERATION; SEROPOSITIVE PATIENTS; INFECTED PATIENTS; EXPRESSION; APOPTOSIS; RISK;
D O I
10.1146/annurev-med-041610-134224
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The classic kidney disease of HIV infection, HIV-associated nephropathy (HIVAN), is an aggressive form of collapsing focal segmental glomerulosclerosis with accompanying tubular and interstitial lesions. HIVAN was first described among African-Americans and Haitian immigrants with advanced HIV disease, an early suggestion of a strong genetic association. This genetic susceptibility was recently linked to polymorphisms on chromosome 22 in individuals of African descent. The association with advanced HIV infection and evidence from HIV-transgenic mice suggested the possibility that HIV directly infects the kidney and that specific HIV gene expression induces host cellular pathways that are responsible for HIVAN pathogenesis. Although combination antiretroviral therapy has substantially reduced the impact of HIVAN in the United States, continued growth of the HIV epidemic in susceptible African populations may have important public health implications. This article reviews recent progress in the pathogenesis and treatment of HIVAN and describes the changing epidemiology of HIV-related kidney disease.
引用
收藏
页码:147 / 159
页数:13
相关论文
共 50 条
  • [21] HIV-associated nephropathy: pathogenesis
    Medapalli, Raj K.
    He, John C.
    Klotman, Paul E.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2011, 20 (03): : 306 - 311
  • [22] The Pathogenesis of HIV-Associated Nephropathy
    Kaufman, Lewis
    Collins, Susan E.
    Klotman, Paul E.
    ADVANCES IN CHRONIC KIDNEY DISEASE, 2010, 17 (01) : 36 - 43
  • [23] Is the prevalence of HIV-associated nephropathy decreasing?
    Ahuja, TS
    Borucki, M
    Funtanilla, M
    Shahinian, V
    Hollander, M
    Rajaraman, S
    AMERICAN JOURNAL OF NEPHROLOGY, 1999, 19 (06) : 655 - 659
  • [24] Viral load and HIV-associated nephropathy
    Izzedine, H
    Wirden, M
    Launay-Vacher, V
    NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (10): : 1072 - 1074
  • [25] HIV-associated nephropathy: Is it going to disappear?
    Marques, LPJ
    Rioja, LS
    NEPHRON, 2000, 85 (02) : 178 - 179
  • [26] HIV-associated nephropathy in African Americans
    Kopp, JB
    Winkler, C
    KIDNEY INTERNATIONAL, 2003, 63 : 43 - 49
  • [27] Podocyte Injury in HIV-Associated Nephropathy
    Mallipattu, Sandeep K.
    He, John C.
    PODOCYTOPATHY, 2014, 183 : 181 - 190
  • [28] HIV-Associated Nephropathy: Experimental Models
    Avila-Casado, M. Carmen
    Fortoul, Teresa I.
    Chugh, Sumant S.
    EXPERIMENTAL MODELS FOR RENAL DISEASES: PATHOGENESIS AND DIAGNOSIS, 2011, 169 : 270 - 285
  • [29] MicroRNAs in HIV-associated nephropathy (HIVAN)
    Cheng, Kang
    Rai, Partab
    Plagov, Andrei
    Lan, Xiqian
    Subrati, Ashaan
    Husain, Mohammad
    Malhotra, Ashwani
    Singhal, Pravin C.
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2013, 94 (01) : 65 - 72
  • [30] Evolving Spectrum of HIV-Associated Nephropathy
    Ahmed, Salman
    Luan Truong
    Eknoyan, Garabed
    Workeneh, Biruh
    NEPHRON CLINICAL PRACTICE, 2012, 121 (3-4): : C131 - C135